SIGA Technologies, Inc. (NASDAQ:SIGA - Get Free Report) was the target of some unusual options trading on Wednesday. Stock traders purchased 1,200 call options on the stock. This is an increase of approximately 1,438% compared to the typical volume of 78 call options.
SIGA Technologies Stock Up 1.3 %
SIGA traded up $0.08 during midday trading on Thursday, reaching $6.47. The company had a trading volume of 297,471 shares, compared to its average volume of 369,272. SIGA Technologies has a 1 year low of $4.26 and a 1 year high of $12.83. The company has a market cap of $461.96 million, a P/E ratio of 5.39 and a beta of 0.94. The business has a 50-day moving average of $6.36 and a two-hundred day moving average of $7.54.
SIGA Technologies (NASDAQ:SIGA - Get Free Report) last released its earnings results on Thursday, November 7th. The company reported $0.02 EPS for the quarter. The company had revenue of $10.01 million for the quarter. SIGA Technologies had a net margin of 49.33% and a return on equity of 49.06%. On average, equities research analysts predict that SIGA Technologies will post 1.04 EPS for the current year.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the company. Larson Financial Group LLC bought a new position in shares of SIGA Technologies in the third quarter worth about $30,000. EP Wealth Advisors LLC bought a new position in SIGA Technologies in the 3rd quarter worth approximately $82,000. XTX Topco Ltd purchased a new stake in SIGA Technologies during the 3rd quarter valued at approximately $85,000. AQR Capital Management LLC bought a new stake in shares of SIGA Technologies during the second quarter valued at approximately $99,000. Finally, China Universal Asset Management Co. Ltd. lifted its holdings in shares of SIGA Technologies by 64.3% in the third quarter. China Universal Asset Management Co. Ltd. now owns 13,727 shares of the company's stock worth $93,000 after buying an additional 5,372 shares in the last quarter. Hedge funds and other institutional investors own 55.40% of the company's stock.
About SIGA Technologies
(
Get Free Report)
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Recommended Stories
Before you consider SIGA Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SIGA Technologies wasn't on the list.
While SIGA Technologies currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
